Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate-Reference-Cited by-同舟云学术

Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate

Published:2017-12 Issue: Volume:148 Page:43-52
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Kim Min-Chul,Lee Yu-Na,Kim Yu-Jin,Choi Hyo-Jick,Kim Ki-Hye,Lee Youn-Jeong,Kang Sang-Moo

Funder

NIH

NIAID

Animal and Plant Quarantine Agency

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference49 articles.

1. Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice;Alvarez;Vaccine,2013

2. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design;Bessa;Eur. J. Immunol.,2008

3. Antibody response to the M2 protein of influenza A virus expressed in insect cells;Black;J. Gen. Virol.,1993

4. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines;Cox;Scand. J. Immunol.,2004

5. Universal influenza A vaccine: optimization of M2-based constructs;De Filette;Virology,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Single-Component Multilayered Self-Assembling Protein Nanoparticle Vaccine Based on Extracellular Domains of Matrix Protein 2 against Both Influenza A and B;Vaccines;2024-08-28

2. A Universal, Single-Component Multilayered Self-Assembling Protein Nanoparticle Vaccine Based on Extracellular Domains of Matrix Protein 2 Against Both Influenza A and B;2024-07-07

3. Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses;Virology;2022-09

4. Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes;Virology;2022-01

5. Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin;Scientific Reports;2021-02-18